{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:17:05Z","timestamp":1788513425917,"version":"build-2803163510"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\u00b9\u2078F-DOPA PET\/CT is a well-established imaging modality in pediatric nuclear medicine, with applications in both oncologic and nononcologic conditions. Common indications include brain tumors, neuroendocrine neoplasms, neuroblastoma, and congenital hyperinsulinism. Here, we present an unusual case of \u00b9\u2078F-DOPA uptake in Ewing sarcoma. This case illustrates a potential diagnostic pitfall, emphasizing that \u00b9\u2078F-DOPA avidity is not specific for neuroendocrine or neuroblastic tumors and may occur in non-neuroendocrine malignancies.<\/jats:p>","DOI":"10.1097\/rlu.0000000000006687","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:00:20Z","timestamp":1788512420000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Unexpected \u00b9\u2078F-DOPA Uptake in Pediatric Posterior Mediastinal Ewing Sarcoma: A Diagnostic Pitfall in Pediatric Oncology"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-4560","authenticated-orcid":false,"given":"Kailash","family":"Chaurasiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Dunaikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kireeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Shamanskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Likar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing\u2019s sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N Engl J Med"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.semnuclmed.2016.12.004","article-title":"The role of 18F-FDG-PET\/CT in pediatric sarcoma","volume":"47","author":"Harrison","year":"2017","journal-title":"Semin Nucl Med"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/jcm10081685","article-title":"Ewing sarcoma-diagnosis, treatment, clinical challenges and future perspectives","volume":"10","author":"Z\u00f6llner","year":"2021","journal-title":"J Clin Med"},{"key":"R4-20260904","first-page":"64","article-title":"Clinical application of 18F-DOPA PET\/TC in pediatric patients","volume":"11","author":"Masselli","year":"2021","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13139-024-00899-6","article-title":"Korean Society of Nuclear Medicine Medical Affairs Committee. 18F-FDOPA PET\/CT in oncology: procedural guideline by the Korean Society of Nuclear Medicine","volume":"59","author":"Park","year":"2025","journal-title":"Nucl Med Mol Imaging"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2967\/jnumed.109.065664","article-title":"18F-FDOPA: a multiple-target molecule","volume":"50","author":"Minn","year":"2009","journal-title":"J Nucl Med"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/pin.12323","article-title":"L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors","volume":"65","author":"Koshi","year":"2015","journal-title":"Pathol Int"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"1001318","DOI":"10.3389\/fonc.2022.1001318","article-title":"Amino acid metabolism in primary bone sarcomas","volume":"12","author":"Jim\u00e9nez","year":"2022","journal-title":"Front Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:00:22Z","timestamp":1788512422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":8,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006687","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2026-06-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}